Serum matrix metalloproteinase 3 in detecting remitting seronegative symmetrical synovitis with pitting edema syndrome: A case report

Table 1 Laboratory data on admission

Parameter	Recorded value	Standard value
White blood cell count, /μL	5100	4500-7500
Neutrophil	75%
Lymphocyte	18%
Monocyte	6%
Hemoglobin, g/dL	12.2	11.3-15.2
Hematocrit	37.1%	36%-45%
Platelet, ×103/μL	463	130-350
Erythrocyte sedimentation rate, mm/h	99	20
C-reactive protein, mg/dL	20.8	≤ 0.60
Total protein, g/dL	6.8	6.9-8.4
Albumin, g/dL	3.2	3.9-5.1
Aspartate aminotransferase, U/L	12	11-30
Alanine aminotransferase, U/L	12	4-30
Lactate dehydrogenase, U/L	146	109-216
Creatine phosphokinase, U/L	20	40-150
Blood nitrogen urea, mg/dL	17.4	8-20
Creatinine, mg/dL	0.48	0.63-1.03
Sodium, mEq/L	139	136-148
Potassium, mEq/L	4.3	3.6-5.0
Glucose, mg/dL	98	70-109
Immunoglobulin G, mg/dL	1190	900-2000
C3, mg/dL	128	86-160
C4, mg/dL	25	17-45
Rheumatoid factor, U/mL	2	2
Anti-nuclear Ab	≤ 40	≤ 40
Anti-CCP Ab, U/mL	< 0.6	< 4.5
PR-3-ANCA, U/mL	< 1.0	< 3.5
MPO-ANCA, U/mL	< 1.0	<3.5
MMP-3, ng/mL	488	36.9-121
VEGF, pg/mL	135	< 38.3
HLA-B7	(+)

Ab: Antibodies; CCP: Citrullinated peptide; PR-3: Proteinase-3; ANCA: Antineutrophil cytoplasmic antibody; MPO: Myeloperoxidase; MMP-3: Matrix metalloproteinase-3; VEGF: Vascular endothelial growth factor; HLA: Human leukocyte antigen.